- Home
- Publications
- Publication Search
- Publication Details
Title
Ocular Inflammation Induced by Immune Checkpoint Inhibitors
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 11, Issue 17, Pages 4993
Publisher
MDPI AG
Online
2022-08-26
DOI
10.3390/jcm11174993
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer
- (2022) Gyu Eun Hwang et al. DOCUMENTA OPHTHALMOLOGICA
- Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
- (2022) Ming Yi et al. Molecular Cancer
- Molecular Pathways and Mechanisms of LAG-3 in Cancer Therapy
- (2022) Lawrence P. Andrews et al. CLINICAL CANCER RESEARCH
- Case with metastatic cutaneous malignant melanoma that developed Vogt–Koyanagi–Harada-like uveitis following pembrolizumab treatment
- (2021) Hiroko Enomoto et al. DOCUMENTA OPHTHALMOLOGICA
- Ocular side effects of checkpoint inhibitors
- (2021) Carmen Alba-Linero et al. SURVEY OF OPHTHALMOLOGY
- Neuro-ophthalmic Complications of Immune-Checkpoint Inhibitors
- (2021) Loulwah Mukharesh et al. Seminars in Ophthalmology
- Vogt–Koyanagi–Harada‐like syndrome in the setting of combined anti‐PD1/anti‐CTLA4 therapy
- (2021) R. Godse et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Development of Vogt–Koyanagi–Harada Disease-like Uveitis during Treatment by Anti-programmed Death Ligand-1 Antibody for Non-small Cell Lung Cancer: A Case Report
- (2021) Shunichi Suwa et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors
- (2021) Stephan Thurau et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Risk of Ophthalmic Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis
- (2021) Yan-Li Hou et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Ocular surface disease associated with immune checkpoint inhibitor therapy
- (2021) Royce B. Park et al. Ocular Surface
- Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review
- (2021) Busra Yilmaz Tugan et al. Seminars in Ophthalmology
- Immune checkpoint inhibitor–associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation
- (2021) Noémie Chanson et al. EUROPEAN JOURNAL OF CANCER
- Case Report
- (2021) Clara Monferrer Adsuara et al. OPTOMETRY AND VISION SCIENCE
- Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
- (2021) Ine Lambert et al. BMC Ophthalmology
- Ocular adverse events in PD-1 and PD-L1 inhibitors
- (2021) LeAnne Young et al. Journal for ImmunoTherapy of Cancer
- Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer
- (2021) Ryota Ushio et al. INTERNAL MEDICINE
- A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
- (2021) Keisuke Minami et al. Case Reports in Ophthalmology
- Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy
- (2020) Xiaowei Liu et al. Thoracic Cancer
- Vogt‐Koyanagi‐Harada‐like syndrome induced by immune checkpoint inhibitors in a melanoma patient
- (2020) S. Yoshida et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Bilateral Corneal Graft Rejection Associated With Pembrolizumab Treatment
- (2020) Eva Vanhonsebrouck et al. CORNEA
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- Factors associated with ocular adverse event after immune checkpoint inhibitor treatment
- (2020) Yong Joon Kim et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Uveitis Induced by Biological Agents Used in Cancer Therapy
- (2020) Iris Deitch-Harel et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance Analysis
- (2020) David Bomze et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Ocular Complications of Checkpoint Inhibitors and Immunotherapeutic Agents: A Case Series
- (2020) Ruby A. Parikh et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Bilateral multiple serous retinal detachments after treatment with nivolumab: a case report
- (2020) Reina Miyamoto et al. BMC Ophthalmology
- Vogt–Koyanagi–Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report
- (2020) Ryo Kikuchi et al. BMC Ophthalmology
- Sex and Gender Disparities in Melanoma
- (2020) Maria Bellenghi et al. Cancers
- Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience
- (2020) Blake Hugo Fortes et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Nivolumab-Induced Ulcerative Keratitis—A Case Report
- (2020) Gergely Losonczy et al. CORNEA
- Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes
- (2020) Eliot R. Dow et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Immune Checkpoint Inhibitor-Induced Uveitis
- (2020) Emmett T. Cunningham et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry
- (2020) Michel M. Sun et al. OPHTHALMOLOGY
- A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors
- (2019) Patrick Arnaud-Coffin et al. INTERNATIONAL JOURNAL OF CANCER
- Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades
- (2019) Tao Lu et al. Cancer Management and Research
- Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors
- (2019) Suthee Rapisuwon et al. Journal for ImmunoTherapy of Cancer
- Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?
- (2019) Virginie Lemiale et al. Annals of Intensive Care
- Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition
- (2019) Michel M. Sun et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Prevalence and clinical patterns of ocular complications associated with anti-PD-1/PD-L1 anticancer immunotherapy
- (2019) Karen Bitton et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies
- (2019) Carl W. Noble et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy
- (2019) Blake M. Warner et al. ONCOLOGIST
- Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis
- (2019) Sara Touhami et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Vision loss with pembrolizumab treatment: A report of two cases
- (2019) Mohammad Telfah et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Local therapy for cancer therapy-associated uveitis: a case series and review of the literature
- (2019) Arthi Ganesh Venkat et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- CHOROIDAL NEOVASCULARIZATION AND CHORIORETINAL ATROPHY IN A PATIENT WITH MELANOMA-ASSOCIATED RETINOPATHY AFTER IPILIMUMAB/NIVOLUMAB COMBINATION THERAPY
- (2019) Kevin F. Elwood et al. Retinal Cases and Brief Reports
- Bilateral ipilimumab-induced posterior uveitis following treatment for metastatic choroidal melanoma
- (2018) Alexander XJ Tan et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Uvéite bilatérale associée à un traitement par nivolumab
- (2018) A.-L. Rémond et al. JOURNAL FRANCAIS D OPHTALMOLOGIE
- HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy
- (2018) Taku Fujimura et al. JOURNAL OF DERMATOLOGY
- Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors
- (2018) Ioannis Gkiozos et al. Journal of Thoracic Oncology
- Vogt-Koyanagi-Harada Syndrome Induced by Pembrolizumab in a Patient with Non–Small Cell Lung Cancer
- (2018) Tomoki Tamura et al. Journal of Thoracic Oncology
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Chronic Hypotony following Bilateral Uveitis in a Patient Treated with Pembrolizumab for Cutaneous Metastatic Melanoma
- (2018) Gerard Reid et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- CHECKPOINT INHIBITOR IMMUNE THERAPY
- (2018) Lauren A. Dalvin et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Uveal Effusion After Immune Checkpoint Inhibitor Therapy
- (2018) Merina Thomas et al. JAMA Ophthalmology
- Birdshot-like Chorioretinopathy Associated With Pembrolizumab Treatment
- (2018) Luis A. Acaba-Berrocal et al. JAMA Ophthalmology
- Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma
- (2018) Wei Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
- (2018) Cheng Xu et al. BMJ-British Medical Journal
- Checkpoint inhibitor-induced uveitis: a case series
- (2017) Christopher D. Conrady et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Bilateral anterior uveitis and unilateral facial palsy due to ipilimumab for metastatic melanoma in an individual with human leukocyte antigen DR4: A case report
- (2017) Shigeki Numata et al. JOURNAL OF DERMATOLOGY
- Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient
- (2017) Hiroaki Kanno et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Inflammatory Orbitopathy Associated With Ipilimumab
- (2017) Claire A. Sheldon et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity
- (2017) Pui Ying Chan et al. Pigment Cell & Melanoma Research
- Bilateral uveitis and macular edema induced by Nivolumab: a case report
- (2017) Claire Theillac et al. BMC Ophthalmology
- Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report
- (2017) International Journal of Ophthalmology
- Combination Ipilimumab and Nivolumab for Metastatic Melanoma Associated With Ciliochoroidal Effusion and Exudative Retinal Detachment
- (2017) Edmund Tsui et al. JAMA Ophthalmology
- Treatment of Ipilimumab-Induced Vogt-Koyanagi-Harada Syndrome With Oral Dexamethasone
- (2017) Matthew T. Witmer Ophthalmic Surgery Lasers & Imaging Retina
- Full Spectrum: Efficacy and Toxicity of Immunotherapy in Metastatic Melanoma
- (2017) Matthew Zibelman et al. Journal of the National Comprehensive Cancer Network
- Ipilimumab-Induced Hypophysitis and Uveitis in a Patient With Metastatic Melanoma and a History of Ipilimumab-Induced Skin Rash
- (2017) Neelima N. Nallapaneni et al. Journal of the National Comprehensive Cancer Network
- Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report
- (2016) Alfred Basilious et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Cyclosporine for Dry Eye Associated With Nivolumab
- (2016) Alexander T. Nguyen et al. CORNEA
- Ocular and orbital side-effects of checkpoint inhibitors
- (2016) Joëlle Antoun et al. CURRENT OPINION IN ONCOLOGY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- A Case of Bilateral Uveitis and Papillitis in a Patient Treated with Pembrolizumab
- (2016) Khawla Abu Samra et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient
- (2016) Takashi Arai et al. JOURNAL OF DERMATOLOGY
- Pembrolizumab-triggered Uveitis
- (2016) Stefan Diem et al. JOURNAL OF IMMUNOTHERAPY
- Intraocular Inflammation Associated with New Therapies for Cutaneous Melanoma – Case Series and Review
- (2016) F. Fierz et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Bilateral Anterior Uveitis Associated with Nivolumab Therapy
- (2016) Justin Karlin et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes
- (2016) Marcelo Mendes Lavezzo et al. Orphanet Journal of Rare Diseases
- A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma
- (2016) Kirollos S. Hanna PHARMACOTHERAPY
- Autoimmune Arthropathy and Uveitis as Complications of Programmed Death 1 Inhibitor Treatment
- (2016) Guillermo de Velasco et al. Arthritis & Rheumatology
- New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient
- (2015) Elisabetta Miserocchi et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Vogt-Koyanagi-Harada-like Syndrome After CTLA-4 Inhibition With Ipilimumab for Metastatic Melanoma
- (2015) Jason N. Crosson et al. JOURNAL OF IMMUNOTHERAPY
- Ipilimumab-Associated Bilateral Optic Neuropathy
- (2015) Oliver L. Yeh et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Ipilimumab-induced Ocular and Orbital Inflammation—A Case Series and Review of the Literature
- (2015) Evangelia Papavasileiou et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- A Case Report of Orbital Inflammatory Syndrome Secondary to Ipilimumab
- (2015) Amanda D. Henderson et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma
- (2015) Dimosthenis Mantopoulos et al. JAMA Ophthalmology
- The perspective of immunotherapy
- (2014) Christian U. Blank CURRENT OPINION IN ONCOLOGY
- Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma
- (2014) B. Liao et al. NEURO-ONCOLOGY
- Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: A Systematic Review and Meta-analysis
- (2014) Tingkun Shi et al. Scientific Reports
- Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma
- (2014) Joshua S Manusow et al. Journal for ImmunoTherapy of Cancer
- Myosite orbitaire associée à un traitement par ipilimumab
- (2013) M. Lecouflet et al. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma
- (2013) Bobeck S. Modjtahedi et al. Cutaneous and Ocular Toxicology
- The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
- (2013) Caroline J. Voskens et al. PLoS One
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Induced Graves Disease From CTLA-4 Receptor Suppression
- (2011) Gary Borodic et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy
- (2010) Le Min et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Vogt-Koyanagi-Harada Syndrome
- (2009) Wang Fang et al. CURRENT EYE RESEARCH
- The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation
- (2008) J. D. Wolchok et al. ONCOLOGIST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started